Identification of IgE binding to Api g 1-derived peptides
Elvira Ruppel1, Bernhard Aÿ, Prisca Boisguerin
1Allergie-Centrum-Charité, Klinik für Dermatologie und Allergologie, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Chembiochem : a European Journal of Chemical Biology
|September 28, 2010
Summary
Celery allergy diagnosis is improved by identifying specific IgE binding peptides. A new assay accurately distinguishes between celery-allergic and healthy individuals by detecting IgE reactivity to key Api g 1.0101 regions.
Area of Science:
- Immunology
- Allergology
- Biochemistry
Background:
- Celery allergy is common in pollen-sensitized individuals, causing severe reactions.
- Current diagnostic methods like skin prick tests (SPTs) and specific immunoglobulin E (IgE) measurements lack predictive accuracy for clinical symptoms.
- Identifying specific IgE-binding epitopes is crucial for accurate celery allergy diagnosis.
Purpose of the Study:
- To identify specific IgE-binding peptides of the major celery allergen, Api g 1.0101.
- To develop and optimize an immunoassay for detecting IgE reactivity to these peptides.
- To evaluate the diagnostic potential of the developed assay in distinguishing celery-allergic from healthy individuals.
Main Methods:
- Synthesized Api g 1.0101 as an array of overlapping peptides.
- Probed synthesized peptides with sera from 21 celery-allergic and 17 healthy patients.
- Optimized immunoassay parameters including peptide length, density, incubation, and readout.
Main Results:
- Celery-allergic patients' sera showed IgE binding to three distinct regions of Api g 1.0101.
- A peptide containing amino acids 100-126 demonstrated the highest IgE binding, fivefold greater than in healthy controls.
- A specific peptide (VLVPTADGGSIC) within this region was recognized by all allergic patients' sera but none from healthy controls.
Conclusions:
- An improved immunoassay strategy effectively identifies specific IgE binding peptides in celery allergy.
- The assay demonstrates potential for distinguishing celery-allergic patients from healthy individuals.
- Further validation in a larger, well-defined patient cohort is warranted.


